Finally, 16 FRlncRNAs that were differentially expressed between tumor and adjacent normal tissue (AC009779.2, ZFPM2-AS1, AC009005.1, AC074117.1, AC012467.2, AL031985.3, AC009403.1, LUCAT1, AC026369.2, AC068580.3, LINC01871, AL139384.1, TMEM220-AS1, NRAV, AL365203.2, and MIR210HG) were identified and used to establish the prognostic FRlncRNA signature. This evidence concerns the gene TMEM220 and neoplasm.